REPAIR: Remote Ischemic Preconditioning and Risk of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Stent Implantation

Sponsor
Beijing Anzhen Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT01827891
Collaborator
(none)
310
1
2
15
20.6

Study Details

Study Description

Brief Summary

This single-center, randomized controlled trial is to investigate the impact of remote ischemic preconditioning (RIPC) on the risk contrast-induced acute kidney injury and its long-term impact on renal function for patients with diabetes undergoing percutaneous coronary intervention.

Condition or Disease Intervention/Treatment Phase
  • Procedure: remote ischemic preconditioning (RIPC)
N/A

Detailed Description

Patients with diabetes undergoing elective percutaneous coronary intervention in Beijing Anzhen Hospital were enrolled, and all the eligible participants were randomized to either remote ischemic preconditioning (RIPC) group or control group. Those randomized to RIPC group had a pneumatic medical tourniquet cuff (width , 5 cm ; length , 40 cm) placed around their upper arm at < 2 hours before the PCI procedure. The pneumatic medical cuff was inflated to a pressure of 200 mm Hg for 5 minutes , followed by 5 minutes of deflation to allow reperfusion. This procedure was repeated for 3 times. Control participants did not experience this procedure of transient upper-limb ischemia.

Study Design

Study Type:
Interventional
Actual Enrollment :
310 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Remote Ischemic Preconditioning and Risk of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Stent Implantation
Study Start Date :
Mar 1, 2012
Actual Primary Completion Date :
Jan 1, 2013
Anticipated Study Completion Date :
Jun 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: control group

Control participants did not experience the procedure of transient upper-limb ischemia.

Active Comparator: remote ischemic preconditioning (RIPC) group

Those randomized to RIPC group had a pneumatic medical tourniquet cuff (width , 5 cm ; length , 40 cm) placed around their upper arm at < 2 hours before the PCI procedure. The pneumatic medical cuff was inflated to a pressure of 200 mm Hg for 5 minutes , followed by 5 minutes of deflation to allow reperfusion. This procedure was repeated for 3 times.

Procedure: remote ischemic preconditioning (RIPC)
Those randomized to RIPC group had a pneumatic medical tourniquet cuff (width , 5 cm ; length , 40 cm) placed around their upper arm at < 2 hours before the PCI procedure. The pneumatic medical cuff was inflated to a pressure of 200 mm Hg for 5 minutes , followed by 5 minutes of deflation to allow reperfusion. This procedure was repeated for 3 times.

Outcome Measures

Primary Outcome Measures

  1. acute kidney injury [72 hours after procedure]

    The primary study endpoint was AKI, defined as an absolute rise in serum creatinine of ≥ 0.5 mg/dl or a relative increase of ≥ 25% compared to baseline within 72 hours from PCI (the maximal measured concentration of serum creatinine during these 72 hours was used).

Secondary Outcome Measures

  1. relative reduction in estimated glomerular filtration rate [180 days after procedure]

    Secondary endpoints were the relative reduction in estimated glomerular filtration rate (eGFR) as well as all cause mortality, myocardial infarction and stent thrombosis at 30-day and 180-day after procedure.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with diabetes undergoing percutaneous coronary intervention were included.
Exclusion Criteria:
  1. emergency PCI,

  2. baseline troponin value > 0.04 ng/mL,

  3. nicorandil or glibenclamide use (preconditioning-mimetic and preconditioning-blocking medication, respectively),

  4. patient on dialysis,

  5. patients who had some inability to cooperate with the trial,

  6. those who could not give informed consent, and (7) second procedure of staged elective PCI in this hospitalization.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beijing Anzhen Hospital, Capital Medical University Beijing China 100029

Sponsors and Collaborators

  • Beijing Anzhen Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yujie Zhou, professor of cardiology, Vice president of Beijing Anzhen Hospital, Beijing Anzhen Hospital
ClinicalTrials.gov Identifier:
NCT01827891
Other Study ID Numbers:
  • AZ-12
First Posted:
Apr 10, 2013
Last Update Posted:
Apr 10, 2013
Last Verified:
Apr 1, 2013
Keywords provided by Yujie Zhou, professor of cardiology, Vice president of Beijing Anzhen Hospital, Beijing Anzhen Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 10, 2013